查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1835559

微生物组定序服务市场（按样本类型、技术、应用和最终用户）—全球预测 2025-2032

Microbiome Sequencing Services Market by Sample Type, Technology, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年微生物组定序服务市场将成长至 63.8 亿美元，复合年增长率为 15.25%。

主要市场统计数据
基准年2024年 20.4亿美元
预计2025年 23.6亿美元
预测年份：2032年 63.8亿美元
复合年增长率（%） 15.25%

一个重要的背景框架，揭示了技术成熟度、工作流程标准化和资料整合如何重塑服务选择和相关人员的期望。

由于技术创新的加速、应用的多样化以及跨部门合作的加强，微生物组定序服务正在快速发展。这种应用随后为解读洞见提供了必要的背景。定序模式已经成熟，超越了概念验证，能够提供可重复的临床相关数据。样本采集通讯协定正朝着标准化工作流程发展，以减少分析前的差异性。总而言之，这些发展正在重新定义实验室、诊断公司、製药研究人员和环境从业人员采购定序服务的方式，并将结果整合到决策流程中。

重要的是，本概述强调了科学研究能力与商业性部署之间的相互作用。扩增子、总体转录组和鸟枪法宏基因组学方法的进步正在扩大可解决问题的范围，从分类分析到功能推断和转录活性状态。同时，需求模式也在改变。临床和製药行业的相关人员需要经过验证且合规的工作流程和快速的周转，而农业和环境用户则优先考虑可扩展性、在土壤和水等可变基质中的稳健性以及成本效益。因此，相关人员应从预期应用和下游分析的检验来解读技术选择，而不是孤立地看待技术升级。有了这个框架，读者就可以评估针对以下章节中讨论的细分、区域动态以及贸易和政策压力的战术性应对措施。

定序模式的快速发展、严格的工作流程标准化以及以结果为导向的伙伴关係关係如何重新定义服务模式和竞争差异化

微生物组定序领域正在经历一场变革性的转变，涵盖技术创新、价值链重建以及多体学观点的整合。标靶扩增子方法正在优化，以实现经济高效的分类学研究，而鸟枪法宏基因组学和宏转录组学则被用于捕获功能潜力和活跃的基因表现。这种二分法将促成差异化服务，在速度和规模与解析度和可解释性之间取得平衡，迫使服务供应商清晰地描述每种模式的效能范围。

其次，标准化样本处理和品管框架的兴起正在减少研究间差异，并实现更可靠的队列间比较。这种标准化，加上生物资讯学可重复性和容器化工作流程的改进，正在降低临床和工业客户外包的门槛。因此，委外研发机构和专业定序中心正在扩展附加价值服务，例如检验的流程、解释性报告和监管支援。第三，微生物组数据与临床、农业和环境元资料的整合正在推动整合分析平台的发展，这些平台不仅提供原始数据，还提供切实可行的见解。因此，成功的提供者正在从单纯的服务交付转向以结果为导向的伙伴关係关係，强调问题定义、客製化实验设计和以决策为中心的报告。最后，地缘政治和供应链动态正在推动对区域产能和试剂冗余的投资，从而影响整个生态系统的策略伙伴关係和采购决策。

评估关税主导的供应链重组、在地化采购和库存策略如何改变定序服务的采购、检验和伙伴关係方法

2025年美国宣布的关税措施的累积影响正在波及微生物组定序服务中使用的试剂、仪器和辅助耗材的整个供应链。关税带来的成本压力正促使供应商和最终用户重新考虑筹资策略，许多供应商优先考虑供应商多元化和本地製造合作伙伴关係，以减轻影响。同时，经销商和服务实验室正在修改其定价模式，以反映进口设备不断上升的到岸成本，同时平衡限制其完全转嫁给客户的竞争压力。这种紧张局势促使合约谈判倾向于长期供应协议、数量承诺以及供应商和客户之间的库存风险共用合作。

企业因应措施包括储备关键试剂、寻找替代供应商以及加速国产耗材的检验，以确保服务连续性。对平台製造商而言，关税主导的利润率压缩正促使他们探索区域组装和在地化，以在关键市场保持竞争力。同时，研究和临床客户正在调整计划时间表和采购週期，以适应前置作业时间波动，一些客户正在转向更高通量的批量策略，以优化试剂利用率。监管和合规性影响也正在显现，诊断级定序实验室现在必须确保在因关税相关短缺而替代试剂和组件时，经过检验的工作流程不会受到影响。整体而言，关税环境可能会提高供应链弹性和协作采购模式的策略重要性，加速对冗余和近岸外包的投资，并影响供应商的上市选择和伙伴关係的发展。

详细的細項分析揭示了样本类型、定序技术、应用领域和最终用户需求如何决定工作流程设计和价值提案

细分洞察揭示了样本类型、定序技术、应用和最终用户的不同需求动态和服务要求。按样本类型划分，研究和服务通常涉及粪便检体、口腔拭子和唾液、皮肤拭子、各种土壤基质和水样，每种样本都存在独特的分析前限制和提取挑战，从而影响通讯协定选择和预期数据品质。例如，粪便和土壤样本通常需要严格的核酸萃取和抑制剂去除步骤，而口腔和皮肤基质则强调低生物质处理和污染控制。因此，能够针对特定样本类别展示有效提取和品质控制工作流程的定序供应商将获得临床和环境客户的高度信任。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 整合人工智慧和鸟枪法宏基因组学对肠道健康进行预测分析
  • 利用高解析度菌株水平定序资料开发有针对性的益生菌
  • 采用即时奈米孔定序平台在临床环境中进行现场微生物组分析
  • 透过整合来自宏转录组学和代谢体学的多组体学数据，获得全面的微生物组洞察
  • 标准化生物资讯学流程的出现，减少了微生物组序列分析的变异性
  • 使用综合鸟枪法宏基因组学检测进行粪便微生物移植筛检的需求日益增加
  • 基于微生物组的药物发现定序提供者与製药公司之间的策略伙伴关係
  • 不断发展的法规结构以解决临床微生物组定序研究中的数据隐私和伦理问题

第六章 2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 微生物组定序服务市场（依样本类型）

  • 屎
  • 口服
  • 皮肤
  • 土壤
  • 水

9. 微生物组定序服务市场（依技术）

  • 扩增子定序
    • 16S rRNA测序
    • 内部转录间隔序列
  • 总体转录组定序
  • 鸟枪法宏基因组定序

第 10 章微生物组定序服务市场（依应用）

  • 农业和畜牧业
    • 作物品质监测
    • 牲畜健康监测
  • 临床诊断
    • 消化系统疾病的诊断
    • 感染疾病诊断
  • 消费者基因体学
    • 家庭检测
    • 基于临床的检测
  • 环境监测
    • 土壤健康监测
    • 水质监测
  • 药物研发
    • 药物研发
    • 微生物组治疗发展

第 11 章微生物组定序服务市场（依最终用户）

  • 学术研究机构
  • 临床诊断实验室
  • 消费者基因组学公司
  • 合约研究组织
  • 製药和生物製药公司

12. 微生物组定序服务市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 13 章微生物组定序服务市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 微生物组定序服务市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • QIAGEN NV
    • F. Hoffmann-La Roche AG
    • Danaher Corporation
    • Eurofins Scientific SE
    • BGI Genomics Co., Ltd.
    • Novogene Co., Ltd.
    • Adaptive BIoTechnologies Corp.
    • WuXi AppTec Co., Ltd.
Product Code: MRR-036C5CF3A80E

The Microbiome Sequencing Services Market is projected to grow by USD 6.38 billion at a CAGR of 15.25% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.04 billion
Estimated Year [2025] USD 2.36 billion
Forecast Year [2032] USD 6.38 billion
CAGR (%) 15.25%

Essential contextual framing that clarifies how technological maturity, workflow standardization, and data integration are reshaping service selection and stakeholder expectations

The microbiome sequencing services landscape is evolving rapidly, driven by accelerated technological innovation, diversified applications, and intensifying cross-sector collaboration. This introduction synthesizes the essential context needed to interpret subsequent insights: sequencing modalities have matured beyond proof-of-concept to deliver reproducible, clinically relevant data; sample acquisition protocols are converging on standardized workflows that reduce pre-analytical variability; and computational pipelines are being professionalized to handle high-throughput data while meeting regulatory and privacy expectations. Taken together, these developments are redefining how laboratories, diagnostic companies, pharmaceutical researchers, and environmental practitioners procure sequencing services and integrate outputs into decision-making processes.

Importantly, this overview emphasizes the interplay between scientific capability and commercial deployment. Advances in amplicon, metatranscriptomic, and shotgun metagenomic approaches have widened the range of resolvable questions, from taxonomic profiling to functional inference and active transcriptional states. At the same time, demand patterns are shifting: clinical and pharmaceutical stakeholders require validated, compliant workflows with rapid turnaround, whereas agricultural and environmental users prioritize scalability, robustness in variable matrices such as soil and water, and cost-efficiency. Therefore, stakeholders should interpret technology choices through the lens of intended application and downstream analytics rather than as isolated technical upgrades. This framing prepares readers to assess segmentation, regional dynamics, and tactical responses to trade and policy pressures discussed in subsequent sections.

How rapidly advancing sequencing modalities, rigorous workflow standardization, and outcome-oriented partnerships are redefining service models and competitive differentiation

The microbiome sequencing sector is undergoing transformative shifts that span technological innovation, value chain reconfiguration, and integration of multi-omic perspectives. First, sequencing technology trajectories have diverged: targeted amplicon approaches are being optimized for cost-effective taxonomic surveys, while shotgun metagenomics and metatranscriptomics are being deployed to capture functional potential and active gene expression. This bifurcation enables differentiated service offerings where speed and scale are balanced against resolution and interpretability, and it compels service providers to articulate clearly the performance envelope of each modality.

Second, the rise of standardized sample handling and quality-control frameworks is diminishing variability across studies and enabling more reliable cross-cohort comparisons. This standardization, paired with improvements in bioinformatics reproducibility and containerized workflows, lowers barriers to outsourcing for clinical and industrial clients. As a result, contract research organizations and specialized sequencing centers are expanding value-added services such as validated pipelines, interpretive reporting, and regulatory support. Third, the convergence of microbiome data with clinical, agronomic, and environmental metadata is catalyzing the development of integrated analytics platforms that provide actionable insights rather than raw data alone. Consequently, successful providers are shifting from pure service delivery to outcome-oriented partnerships that emphasize problem definition, tailored experimental design, and decision-focused reporting. Finally, geopolitical and supply-chain dynamics are prompting investments in regional capacity and reagent redundancy, which in turn influence strategic partnerships and sourcing decisions across the ecosystem.

Assessing how tariff-driven supply chain realignment, localized sourcing, and inventory strategies are altering procurement, validation, and partnership approaches across sequencing services

The cumulative impact of United States tariff actions announced in 2025 has reverberated across supply chains for reagents, instrumentation, and ancillary consumables used in microbiome sequencing services. Tariff-induced cost pressures have prompted providers and end users to reexamine procurement strategies, with many prioritizing supplier diversification and local manufacturing partnerships to mitigate exposure. In parallel, distributors and service labs have recalibrated pricing models to reflect increased landed costs for imported equipment while balancing competitive pressures that limit full pass-through to customers. This tension has fuelled contract negotiations that favor longer-term supply agreements, volume commitments, and collaborative arrangements that share inventory risk between vendors and clients.

Operational responses have included stockpiling critical reagents, qualifying alternative suppliers, and accelerating validation of domestically produced consumables to ensure continuity of service. For platform manufacturers, tariff-driven margin compression has incentivized exploration of regional assembly and localized component sourcing to maintain competitiveness in key markets. At the same time, research and clinical customers have adjusted project timelines and procurement cycles to accommodate lead-time variability, and some have shifted toward higher-throughput batching strategies to optimize reagent utilization. Regulatory and compliance implications have surfaced as well; laboratories engaged in diagnostic-grade sequencing have had to ensure that validated workflows remain intact when substituting reagents or components due to tariff-related shortages. Overall, the tariff environment has heightened the strategic importance of supply chain resilience and collaborative procurement models, accelerating investments in redundancy and nearshoring that will influence suppliers' go-to-market choices and partnership architectures.

In-depth segmentation analysis revealing how sample type, sequencing technology, application domain, and end-user requirements dictate workflow design and value proposition

Segmentation insights reveal differentiated demand dynamics and service requirements across sample types, sequencing technologies, applications, and end users. Based on sample type, studies and services routinely address fecal specimens, oral swabs and saliva, skin swabs, diverse soil matrices, and water samples, each presenting unique pre-analytical constraints and extraction challenges that influence protocol selection and data quality expectations. For example, fecal and soil samples typically require robust nucleic acid extraction and inhibitor removal steps, while oral and skin matrices emphasize low-biomass handling and contamination control. Consequently, sequencing providers that can demonstrate validated extraction and QC workflows for specific sample classes often capture higher confidence from clients in clinical and environmental domains.

Based on technology, service portfolios are organized around amplicon sequencing, metatranscriptomic sequencing, and shotgun metagenomic sequencing. Amplicon sequencing is commonly subdivided into 16S rRNA sequencing for bacterial community profiling and Internal Transcribed Spacer (ITS) sequencing for fungal community characterization, offering cost-effective taxonomic resolution for many surveillance and exploratory studies. Shotgun metagenomics delivers broader taxonomic and functional resolution and is preferred when species-level discrimination and genomic context are required, while metatranscriptomic approaches reveal active gene expression patterns that inform mechanistic hypotheses and therapeutic target identification. The selection among these technologies depends on trade-offs between cost, depth, and interpretive complexity, and providers are increasingly packaging hybrid workflows to meet hybrid client needs.

Based on application, the spectrum includes Agricultural & Animal Husbandry, Clinical Diagnostics, Consumer Genomics, Environmental Monitoring, and Pharmaceutical R&D. Agricultural and animal husbandry use cases break down into crop quality monitoring and livestock health monitoring, where actionable outputs feed agronomic decisions and herd health interventions. Clinical diagnostics comprises gastrointestinal disorder diagnosis and infectious disease diagnostics, demanding validated, reproducible pipelines and regulatory alignment. Consumer genomics splits into at-home testing and clinic-based testing, where user experience, data privacy, and interpretive clarity are central. Environmental monitoring is oriented toward soil health monitoring and water quality monitoring, requiring rugged protocols that contend with diverse matrices. Pharmaceutical R&D spans drug discovery and microbiome therapeutics development, necessitating high-resolution functional insights, longitudinal sampling, and integrated omics.

Based on end user, services are tailored for academic and research institutes, clinical diagnostic laboratories, consumer genomics companies, contract research organizations, and pharmaceutical and biopharmaceutical companies. Each end-user class imposes distinct requirements for turnaround time, validation, data governance, and reporting granularity. Academic clients often prioritize methodological flexibility and raw data access, clinical labs require compliance and interpretive certainty, consumer genomics firms emphasize scale and user-friendly reports, CROs focus on programmatic integration and documentation for regulatory filings, and pharmaceutical companies demand rigorous cross-cohort comparability and integration with clinical endpoints. Recognizing these differentiated needs enables service providers to design modular offerings that map technological choices and QA practices to client-specific success criteria.

How distinct regional investment priorities, regulatory frameworks, and capacity distributions influence sequencing service design and global delivery strategies

Regional dynamics continue to shape investment patterns, capability distribution, and regulatory complexity in microbiome sequencing services. In the Americas, strong private-sector investment, a mature clinical diagnostics ecosystem, and dense pharmaceutical and academic networks support sophisticated service offerings that combine high-throughput sequencing with advanced analytics and clinical-grade reporting. In addition, North American clients frequently drive demand for regulatory-compliant pipelines and rapid turnaround, which fosters partnerships between sequencing centers and clinical laboratories to meet stringent validation standards.

Across Europe, Middle East & Africa, the landscape is heterogeneous: Western European markets emphasize rigorous data protection, well-defined clinical pathways, and collaborative public-private research consortia, while emerging markets within the region demonstrate varied capacity and growing interest in affordable, scalable surveillance solutions for environmental and agricultural applications. Regulatory harmonization efforts and cross-border research initiatives are important trends that influence both sample movement and service deployment strategies across this region.

In the Asia-Pacific region, rapid capacity expansion, significant public research investment, and a growing base of biotech companies are accelerating adoption. Providers in this region are building integrated service models that prioritize cost efficiency and scalability while addressing local language, regulatory, and logistics requirements. Collectively, these regional patterns suggest that providers seeking global reach should balance centralized high-value capabilities with strategically located regional nodes to optimize cost, compliance, and responsiveness to local end-user needs.

Profiles of differentiated company strategies emphasizing integration, validated analytics, and collaborative ecosystems that accelerate adoption and sustain competitive advantage

Key company insights focus on capabilities, strategic positioning, and collaborative models that differentiate leading service providers and technology vendors. Market leaders tend to combine robust laboratory execution with end-to-end bioinformatics, offering validated pipelines, transparent QA metrics, and reproducible reporting formats that satisfy clinical, research, and commercial clients alike. Competitive advantage is often derived from proprietary sample preparation chemistries, validated data interpretation modules that translate complex outputs into decision-ready reports, and strong customer success functions that support study design and regulatory documentation.

Many successful organizations have pursued vertical integration to control critical parts of the value chain, including reagent development, library preparation kits, and data-hosting platforms, thereby reducing reliance on third-party suppliers and improving margin visibility. Others have adopted a modular partnership strategy, creating ecosystems that link specialized sample-prep labs, sequencing centers, and interpretive analytics firms to offer flexible, scalable solutions. Strategic collaborations with pharmaceutical companies and agricultural firms are common, driven by the need to co-develop validated assays, run large-scale longitudinal studies, and translate multi-omic findings into product development hypotheses. Finally, an emerging cohort of companies is differentiating through standards leadership-investing in interlaboratory reproducibility studies, open benchmarking datasets, and participation in regulatory working groups-to build trust and lower barriers to adoption among risk-averse end users.

Actionable strategic and operational imperatives for providers to strengthen resilience, deepen client value, and accelerate validated adoption across applications

Industry leaders should adopt a portfolio of strategic actions to capture value and mitigate risk as the microbiome sequencing landscape matures. First, prioritize investment in validated, application-specific workflows that are demonstrably reproducible across sample types and that incorporate clear QA/QC gates; this reduces client onboarding friction and protects service credibility in regulated contexts. Second, develop supplier diversification and regional sourcing strategies to buffer against tariff-driven supply shocks and logistical disruptions, complemented by formal contingency plans and multi-supplier qualification processes. Third, invest in interpretive analytics and outcome-focused reporting that translate sequencing outputs into actionable recommendations for clinical decisions, agronomic management, or therapeutic development, thereby increasing the utility and perceived value of services.

Additionally, cultivate deep partnerships with end users to co-develop assays and longitudinal study frameworks that align platform capabilities with specific program objectives. This collaborative model shortens validation cycles and generates reference datasets that solidify commercial differentiation. From an operational perspective, implement modular pricing and service tiers that align with client sophistication-from raw data delivery for academic clients to turnkey, validated reports for clinical customers-so providers can capture cross-segment demand without compromising specialization. Finally, engage proactively with regulators, standards bodies, and interlaboratory consortia to influence emerging guidelines, demonstrate compliance, and build trust-actions that will lower barriers for diagnostic and therapeutic applications over time.

Methodical approach combining literature synthesis, expert interviews, technical benchmarking, and supply-chain diagnostics to produce robust actionable insights

The research methodology underpinning this analysis combined multi-source evidence synthesis, stakeholder interviews, technical assessment, and supply-chain diagnostics to ensure robust, actionable findings. Desk research synthesized peer-reviewed literature, technical white papers, regulatory guidance documents, and technology roadmaps to construct a baseline understanding of sequencing modalities, sample-specific constraints, and analytical approaches. This secondary work was complemented by targeted primary interviews with laboratory directors, bioinformatics leaders, procurement specialists, and application scientists to surface operational realities, adoption barriers, and validation priorities that are not always visible in published literature.

Technical assessments included comparative review of lab workflows and bioinformatics pipelines to evaluate reproducibility, contamination control, and interpretive clarity across amplicon, shotgun metagenomic, and metatranscriptomic approaches. Supply-chain diagnostics evaluated reagent and instrument sourcing pathways, inventory strategies, and tariff exposure to identify resilience gaps and near-term operational risks. Findings were triangulated across sources and subjected to sensitivity checks to ensure internal consistency. Where appropriate, limitations and assumptions are clearly documented to help readers interpret the implications for different end-user contexts and to guide further deep-dive analysis tailored to specific operational needs.

Consolidated synthesis highlighting how technical plurality, validation rigor, and supply-chain resilience collectively determine the pace of practical adoption and commercialization

In conclusion, the microbiome sequencing services landscape is transitioning from a fragmented research-oriented market toward a more structured, application-driven ecosystem. Technological plurality-spanning amplicon, shotgun metagenomic, and metatranscriptomic approaches-creates opportunities for differentiated service models that address distinct resolution, cost, and interpretive requirements. Concurrently, the increasing emphasis on workflow standardization, validated analytics, and regulatory alignment is reshaping buyer expectations and elevating the importance of demonstrated reproducibility. Supply-chain pressures, including tariff-related disruptions, have highlighted the strategic value of supplier diversification and regional capacity, prompting both nearshoring and collaborative procurement strategies.

For stakeholders, success depends on aligning technical capabilities with specific application needs, investing in outcome-oriented analytics, and engaging in partnerships that accelerate validation and adoption. By integrating these priorities-resilient operations, targeted productization, and proactive regulatory engagement-providers and end users can convert scientific potential into practical, decision-ready insights that deliver value across clinical, agricultural, environmental, and pharmaceutical domains.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence with shotgun metagenomics for predictive gut health analytics
  • 5.2. Development of targeted probiotics informed by high-resolution microbial strain-level sequencing data
  • 5.3. Adoption of real-time nanopore sequencing platforms for onsite microbiome profiling in clinical settings
  • 5.4. Integration of multiomics data from metatranscriptomics and metabolomics for comprehensive microbiome insights
  • 5.5. Emergence of standardized bioinformatics pipelines to reduce variability in microbiome sequencing analysis
  • 5.6. Growing demand for fecal microbiota transplantation screening using comprehensive shotgun metagenomic assays
  • 5.7. Strategic partnerships between sequencing providers and pharmaceutical companies for microbiome-based drug discovery
  • 5.8. Regulatory frameworks evolving to address data privacy and ethical concerns in clinical microbiome sequencing studies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Microbiome Sequencing Services Market, by Sample Type

  • 8.1. Fecal
  • 8.2. Oral
  • 8.3. Skin
  • 8.4. Soil
  • 8.5. Water

9. Microbiome Sequencing Services Market, by Technology

  • 9.1. Amplicon Sequencing
    • 9.1.1. 16S Rrna Sequencing
    • 9.1.2. Internal Transcribed Spacer Sequencing
  • 9.2. Metatranscriptomic Sequencing
  • 9.3. Shotgun Metagenomic Sequencing

10. Microbiome Sequencing Services Market, by Application

  • 10.1. Agricultural & Animal Husbandry
    • 10.1.1. Crop Quality Monitoring
    • 10.1.2. Livestock Health Monitoring
  • 10.2. Clinical Diagnostics
    • 10.2.1. Gastrointestinal Disorder Diagnosis
    • 10.2.2. Infectious Disease Diagnostics
  • 10.3. Consumer Genomics
    • 10.3.1. At-Home Testing
    • 10.3.2. Clinic-Based Testing
  • 10.4. Environmental Monitoring
    • 10.4.1. Soil Health Monitoring
    • 10.4.2. Water Quality Monitoring
  • 10.5. Pharmaceutical R&D
    • 10.5.1. Drug Discovery
    • 10.5.2. Microbiome Therapeutics Development

11. Microbiome Sequencing Services Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. Clinical Diagnostic Laboratories
  • 11.3. Consumer Genomics Companies
  • 11.4. Contract Research Organizations
  • 11.5. Pharmaceutical & Biopharmaceutical Companies

12. Microbiome Sequencing Services Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Microbiome Sequencing Services Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Microbiome Sequencing Services Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Illumina, Inc.
    • 15.3.2. Thermo Fisher Scientific Inc.
    • 15.3.3. QIAGEN N.V.
    • 15.3.4. F. Hoffmann-La Roche AG
    • 15.3.5. Danaher Corporation
    • 15.3.6. Eurofins Scientific SE
    • 15.3.7. BGI Genomics Co., Ltd.
    • 15.3.8. Novogene Co., Ltd.
    • 15.3.9. Adaptive Biotechnologies Corp.
    • 15.3.10. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. MICROBIOME SEQUENCING SERVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. MICROBIOME SEQUENCING SERVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MICROBIOME SEQUENCING SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY FECAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY FECAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY FECAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY FECAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY FECAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY FECAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ORAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ORAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ORAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ORAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SKIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SKIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SKIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SKIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SKIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SKIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INTERNAL TRANSCRIBED SPACER SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INTERNAL TRANSCRIBED SPACER SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INTERNAL TRANSCRIBED SPACER SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INTERNAL TRANSCRIBED SPACER SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INTERNAL TRANSCRIBED SPACER SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INTERNAL TRANSCRIBED SPACER SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CROP QUALITY MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CROP QUALITY MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CROP QUALITY MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CROP QUALITY MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CROP QUALITY MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CROP QUALITY MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY LIVESTOCK HEALTH MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY LIVESTOCK HEALTH MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY LIVESTOCK HEALTH MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY LIVESTOCK HEALTH MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY LIVESTOCK HEALTH MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY LIVESTOCK HEALTH MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GASTROINTESTINAL DISORDER DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GASTROINTESTINAL DISORDER DIAGNOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GASTROINTESTINAL DISORDER DIAGNOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GASTROINTESTINAL DISORDER DIAGNOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GASTROINTESTINAL DISORDER DIAGNOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GASTROINTESTINAL DISORDER DIAGNOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AT-HOME TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AT-HOME TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AT-HOME TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AT-HOME TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AT-HOME TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AT-HOME TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINIC-BASED TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINIC-BASED TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINIC-BASED TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINIC-BASED TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINIC-BASED TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINIC-BASED TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL HEALTH MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL HEALTH MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL HEALTH MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL HEALTH MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL HEALTH MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL HEALTH MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER QUALITY MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER QUALITY MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER QUALITY MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER QUALITY MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER QUALITY MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER QUALITY MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY MICROBIOME THERAPEUTICS DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY MICROBIOME THERAPEUTICS DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY MICROBIOME THERAPEUTICS DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY MICROBIOME THERAPEUTICS DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY MICROBIOME THERAPEUTICS DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY MICROBIOME THERAPEUTICS DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE